Autologous tumor vaccine modified with recombinant new castle disease virus expressing IL-7 promotes antitumor immune response
/in International Publications, Newcastle Disease Virus /von 2014-06-18 / J. Immunol. 2014 Jul;193(2):735-45Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer
/in International Publications, Newcastle Disease Virus /von 2014-06-11 / Front Oncol 2014;4:145Ovarian cancer biology and immunotherapy
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2014-06-09 / Int. Rev. Immunol. 2014 Oct;33(5):428-40Regulatory T-cell inhibition plus antitumor immunotherapy targeted against cytomegalovirus (CMV) in patients with newly diagnosed glioblastoma multiforme (GBM).
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3069)A randomized, double-blind, placebo-controlled phase 2 trial of dendritic cell (DC) vaccination with ICT-107 in newly diagnosed glioblastoma (GBM) patients.
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 2005)Potentiation of immune checkpoint blockade cancer immunotherapy with oncolytic virus.
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3051)γδ T cells in combination with Newcastle disease virus and dendritic cell therapy as a novel immunotherapeutic approach in treating of advanced lung cancer.
/in Dendritic Cells, International Publications, Newcastle Disease Virus, NSCLC, SCLC /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3062)Randomized phase II study with dendritic cell (DC) immunotherapy in patients with resected hepatic metastasis of colorectal carcinoma.
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr TPS3129)Cancer immunotherapy of patients with the biochemical relapse of the prostate cancer using dendritic cell-based vaccine DCVAC/PCa.
/in Dendritic Cells, International Publications, Prostate Cancer /von 2014-06-01 / J Clin Oncol 32:5s, 2014 (suppl; abstr 3099)
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution